Clinical characteristics of community-acquired acute pyelonephritis caused by ESBL-producing pathogens in South Korea.
about
Epidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysisRisk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country.Impact of extended-spectrum β-lactamase production on treatment outcomes of acute pyelonephritis caused by escherichia coli in patients without health care-associated risk factors.A comparison of the clinical characteristics of elderly and non-elderly women with community-onset, non-obstructive acute pyelonephritis.Community-Onset Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Invasive Infections in Children in a University Hospital in France.Escherichia coli sequence type 131: epidemiology and challenges in treatment.Multidrug-resistant Escherichia coli in Asia: epidemiology and management.Activity of temocillin and 15 other agents, including fosfomycin and colistin, against Enterobacteriaceae in Hong Kong.Prospective cohort study of risk factors for extended-spectrum ß-lactamase-producing Escherichia coli urinary tract infections in elderly patients admitted to hospital.Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration.Antimicrobial Susceptibilities of Enterobacteriaceae in Community-Acquired Urinary Tract Infections during a 5-year Period: A Single Hospital Study in Korea.Clinical Practice Guidelines for the Antibiotic Treatment of Community-Acquired Urinary Tract Infections.Childhood urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and empiric therapy.Community-Acquired Urinary Tract Infection by in the Era of Antibiotic Resistance
P2860
Q28073332-8025327B-B175-404B-A797-10EABD15C585Q34920553-0693DB9D-02A3-4559-AE23-70DE9E7F7EF1Q35168939-8D1A2999-C6FB-4A99-B73B-1B7D1570DAB6Q35626267-E5CBB7B9-7F2E-4D2E-9721-12F8A357B5E1Q37205420-C41BCE28-01D2-4FE6-B0A0-CA3DD661DD37Q38201515-1A217CCE-1A9E-49CF-B8CF-415B1C63FF5FQ38389612-9B0B4778-6467-43D2-82E0-8AA95DEA0933Q38608789-D234C88E-C976-4B43-847B-72199BE02CABQ40066430-AD3F15DC-9B15-4B70-9142-B08C9ED83F85Q40886408-1E324984-7125-4898-BFAB-0BE2BFBE559DQ41644266-B58118C7-37CA-4CC3-8990-309B185E9D5FQ42366693-FE5613CA-989C-4DE2-A65D-628288E7E333Q53074500-A759A53C-335C-4839-8C01-C683FE558D78Q53765869-C4056AED-BF71-464A-B1B3-D9F53C3B4D4EQ57821217-ECA6A63D-166F-4013-8C98-EDC070C5768A
P2860
Clinical characteristics of community-acquired acute pyelonephritis caused by ESBL-producing pathogens in South Korea.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Clinical characteristics of co ...... cing pathogens in South Korea.
@en
Clinical characteristics of co ...... cing pathogens in South Korea.
@nl
type
label
Clinical characteristics of co ...... cing pathogens in South Korea.
@en
Clinical characteristics of co ...... cing pathogens in South Korea.
@nl
prefLabel
Clinical characteristics of co ...... cing pathogens in South Korea.
@en
Clinical characteristics of co ...... cing pathogens in South Korea.
@nl
P2093
P2860
P1433
P1476
Clinical characteristics of co ...... cing pathogens in South Korea.
@en
P2093
H J Cheong
P2860
P2888
P304
P356
10.1007/S15010-013-0441-Z
P50
P577
2013-03-16T00:00:00Z